eCARTv5 Clinical Deterioration Suite (eCART) vs Cortex

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

Cortex

by Cortex

AI Verdict

AgileMD's eCARTv5 is an FDA-cleared Software as a Medical Device specifically designed for continuous patient risk assessment and prediction of clinical deterioration in hospitalized adults, integrating directly with EHRs to guide care with embedded clinical pathways. Cortex Workspace, while also a HIPAA-compliant AI platform for healthcare, focuses more broadly on streamlining workflows, enhancing decision-making, and assisting with clinical documentation across various specialties. Therefore, while both offer clinical decision support, eCARTv5 is a specialized tool for a critical care-focused use case, whereas Cortex Workspace provides a more general AI platform for diverse healthcare operational and administrative tasks.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your hospital needs an FDA-cleared, AI-powered solution for continuous, real-time patient risk assessment and early warning of clinical deterioration (e.g., sepsis, respiratory failure, or transfer to ICU). This tool is ideal for hospitals aiming to reduce preventable adverse outcomes and streamline care with embedded clinical pathways, minimizing false alarms and clinician workload.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose Cortex if…

Choose Cortex if you are an individual physician, mid-sized engineering organization, or large enterprise seeking a secure, HIPAA-compliant AI platform to streamline a broad range of healthcare workflows and enhance decision-making. This platform is well-suited for tasks like clinical documentation assistance, managing patient engagement, optimizing clinic operations, and leveraging AI for data analysis and predictive modeling for areas such as hospital readmission risk.

View Cortex →

When choosing between eCARTv5 Clinical Deterioration Suite and Cortex, physicians should consider their primary need: specialized patient risk assessment or a versatile AI workspace. eCARTv5 is an FDA-cleared, AI-powered Software as a Medical Device specifically designed for continuous assessment and prediction of clinical deterioration in hospitalized adult patients. It integrates with EHRs to provide real-time risk stratification and embedded clinical pathways, making it ideal for critical care, emergency medicine, and hospital medicine settings where early warning and guided intervention for patient decline are paramount. Its key practical difference lies in its singular focus and regulatory clearance for predicting specific clinical outcomes.

Cortex, on the other hand, offers a broader, secure, HIPAA-compliant AI platform aimed at streamlining general healthcare workflows and enhancing decision-making. While it provides clinical documentation assistance and data analysis capabilities, it is not an FDA-cleared medical device for specific diagnostic or prognostic claims. Cortex is best suited for physicians and organizations seeking a flexible AI environment to manage various tasks, from general productivity to integrating with different AI providers for diverse applications. Physicians in family medicine or internal medicine looking for a customizable AI tool to assist with documentation and general workflow improvements, rather than a specialized risk prediction system, would find Cortex more appropriate. The key practical difference is Cortex’s general-purpose utility versus eCARTv5’s specialized, regulated function.

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Cortex
Pricing	Contact vendor for tailored quote.	Starts free, then $29/month for individual plan (save 10% annually). other plans: enthusiast ($99/month), business ($349/month), enterprise (contact sales).
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud-based (SaaS).
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Not applicable AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cortex

Cortex offers a free tier and a 7-day free trial, making it easier for users to explore and assess its usability before committing. It also boasts a mobile app and support for 43 languages, suggesting a broader focus on user accessibility and experience. While eCART integrates with EHRs, its lack of public pricing or trial information makes it harder to evaluate initial usability from a user's perspective.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

eCARTv5 is an FDA-cleared Software as a Medical Device (SaMD) specifically designed for continuous patient risk assessment and prediction of clinical deterioration, with embedded clinical pathways for care guidance. This direct clinical application and regulatory clearance indicate a strong focus on delivering measurable clinical value. Cortex, while offering clinical documentation assistance and workflow streamlining, is a more general AI platform and lacks the specific clinical validation and regulatory clearance of eCART for direct patient care decisions.

Pricing & Value

Cortex

Cortex provides transparent pricing, including a free tier and tiered plans, allowing users to understand costs upfront and scale according to their needs. This transparency and flexibility offer clear value. eCART's pricing is only available upon contacting the vendor, which makes it difficult to assess its value proposition without a direct inquiry.

Enterprise Readiness

eCARTv5 Clinical Deterioration Suite (eCART)

eCART is an FDA-cleared SaMD that integrates directly into EHR systems, a critical requirement for enterprise healthcare environments. Its focus on minimizing false alarms and providing reporting and benchmarking capabilities also points to its readiness for large-scale clinical deployment. While Cortex targets larger enterprises and offers HIPAA compliance and BAA, eCART's specific regulatory clearance and deep EHR integration for a critical clinical function give it an edge in enterprise readiness for direct patient care.

Innovation

eCARTv5 Clinical Deterioration Suite (eCART)

eCART's continuous, AI-powered prediction of clinical deterioration hours before critical illness, coupled with embedded clinical pathways, represents a significant innovation in proactive patient care. Its ability to integrate up to 97 variables for real-time risk assessment showcases advanced AI application in a critical healthcare domain. Cortex, while innovative as an AI platform, is more focused on streamlining existing workflows and providing a secure AI workspace rather than a novel clinical prediction capability.

Support & Docs

Tie

Neither tool provides explicit details about their support channels or documentation availability in the provided information. While both are enterprise-grade solutions, suggesting robust support, there isn't enough information to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Cortex
Name	eCARTv5 Clinical Deterioration Suite (“eCART”)	Cortex
Company	AgileMD	Cortex
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	Secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
Key Features	AI-powered clinical deterioration prediction, Continuous patient risk assessment (death or ICU transfer), EHR integration with real-time data (up to 97 variables), Embedded clinical pathways for care guidance, Early warning system (alerts hours before critical illness), Risk stratification (eCART score and risk designation), Minimizes false alarms and clinician workload, Reporting and benchmarking capabilities	Secure AI workspace, HIPAA compliant, Integration with healthcare systems, Streamlined workflows, Data analysis capabilities, Clinical documentation assistance
Free Trial	Not specified	1
Specialties	Critical Care, Emergency Medicine, Hospital Medicine	Family Medicine, Hospital Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and Cortex.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with existing EHR systems and what is the depth of that integration?

eCARTv5 is designed for direct integration with EHR systems, leveraging real-time data from up to 97 variables for continuous patient risk assessment. Cortex Workspace also offers integration with healthcare systems, with some versions aiming to replace CRM, intake, scheduling, and even the EHR itself, or building compliant workarounds when direct vendor integration is challenging.

What is the accuracy and sensitivity of each tool in its respective clinical application?

eCARTv5 has demonstrated strong accuracy in predicting clinical deterioration, with an AUROC of 0.834 in retrospective validation and consistent performance across various patient subgroups. Its sensitivity at a moderate-risk threshold was 51.8% with a positive predictive value of 9.0%, improving to 14.2% PPV at a high-risk threshold. Cortex's accuracy and sensitivity are not detailed in the provided information, but it focuses on streamlining workflows and enhancing decision-making through AI.

What is the typical learning curve for physicians and clinical staff using these tools?

eCARTv5 provides an early warning system with embedded clinical pathways, suggesting a guided workflow that may reduce the learning curve for interpreting risk scores and following care protocols. Cortex Workspace is designed to streamline healthcare workflows and offers clinical documentation assistance, which could imply a focus on user-friendly interfaces to minimize the learning curve for its AI-powered features.

What kind of audit trail features do these tools offer to support clinical governance and accountability?

eCARTv5 offers reporting and benchmarking capabilities, which can contribute to an audit trail of its performance and impact on patient outcomes. Cortex provides comprehensive audit logs that document detailed records of actions taken within the workspace, including who made a change, when it happened, and what was altered, with some versions offering a tamper-evident, hash-chained Trust Ledger for provable records.

How do these tools support multi-site rollouts and ensure consistent performance across different clinical environments?

eCARTv5's development and validation included multicenter retrospective and prospective studies across geographically diverse health systems, suggesting its suitability for multi-site deployments and consistent performance. Cortex, particularly in its enterprise offerings, is designed for larger organizations and aims to bring consistency to decision-making and embed intelligence into workflows, which would be beneficial for multi-site rollouts.

Beyond HIPAA, what additional security measures are in place to protect patient data and ensure data integrity?

eCARTv5 operates as an FDA-cleared Software as a Medical Device, implying adherence to rigorous security and data integrity standards beyond general HIPAA compliance. Cortex emphasizes a secure AI workspace and some versions detail measures like AES-256 encryption, regular risk assessments, penetration tests, web application firewalls, vulnerability management, and endpoint security.

Can these tools provide customer references or case studies to demonstrate their value in similar clinical settings?

AgileMD, the company behind eCARTv5, has publications detailing the development and validation of eCARTv5, and mentions measuring the return on investment, which often accompanies customer success stories. Cortex, particularly the Snowflake Cortex AI platform, has publicly available customer references and case studies from various industries, including healthcare, demonstrating its application and value.